“Right now, we are blind and don’t know what’s working and what’s not. We need to connect the dots on medical impact to make better decisions, be more strategic, and see the trends. It’s crucial for the future of medical affairs". - Toni Buron, Regional Medical Head, Europe, Novartis
 

In this episode of Veeva’s podcast series, “What Pharma Needs Next”, Christoph Bug, VP Global Medical at Veeva, speaks to several industry experts about the ongoing transformation of medical affairs to become a more strategic, data-driven decision-making organization.

Learn more about measuring medical impact.

More Customer Stories

Measuring the Impact of Medical Affairs
Read Impact Paper
Taking Medical Affairs to the Next Level
Hear About the Future of Medical Affairs
Idorsia: Maximizing the Value of Veeva CRM for Field Medical
Watch Video on Medical CRM

Interested in learning more about Veeva?